Omeros (OMER) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.24% |
| Dec 31, 2025 | -376.11% |
| Sep 30, 2025 | 35.03% |
| Jun 30, 2025 | -5.97% |
| Mar 31, 2025 | 41.85% |
| Dec 31, 2024 | 63.19% |
| Sep 30, 2024 | 22.44% |
| Jun 30, 2024 | 31.19% |
| Mar 31, 2024 | -166.98% |
| Dec 31, 2023 | 44.62% |
| Sep 30, 2023 | 9.07% |
| Jun 30, 2023 | 8.09% |
| Mar 31, 2023 | -90.50% |
| Dec 31, 2022 | 34.25% |
| Sep 30, 2022 | -141.93% |
| Jun 30, 2022 | 55.52% |
| Mar 31, 2022 | -75.16% |
| Dec 31, 2021 | -212.21% |
| Sep 30, 2021 | 31.61% |
| Jun 30, 2021 | 26.68% |
| Mar 31, 2021 | 25.56% |
| Dec 31, 2020 | 12.10% |
| Sep 30, 2020 | -852.14% |
| Jun 30, 2020 | 70.12% |
| Mar 31, 2020 | 11.25% |
| Dec 31, 2019 | -122.07% |
| Sep 30, 2019 | 14.06% |
| Jun 30, 2019 | 32.53% |
| Mar 31, 2019 | 21.99% |
| Dec 31, 2018 | -9.76% |
| Sep 30, 2018 | 37.61% |
| Jun 30, 2018 | -21.41% |
| Mar 31, 2018 | 13.06% |
| Dec 31, 2017 | 3.53% |
| Sep 30, 2017 | -192.62% |
| Jun 30, 2017 | 11.84% |
| Mar 31, 2017 | 25.76% |
| Dec 31, 2016 | 4.45% |
| Sep 30, 2016 | -123.39% |
| Jun 30, 2016 | -60.35% |
| Mar 31, 2016 | 53.14% |
| Dec 31, 2015 | 19.25% |
| Sep 30, 2015 | 31.97% |
| Jun 30, 2015 | 26.57% |
| Mar 31, 2015 | -917.46% |
| Dec 31, 2014 | 68.38% |
| Sep 30, 2014 | 41.86% |
| Jun 30, 2014 | 28.22% |
| Mar 31, 2014 | -270.11% |
| Dec 31, 2013 | -56.71% |
| Sep 30, 2013 | 55.15% |
| Jun 30, 2013 | -45.89% |
| Mar 31, 2013 | 38.47% |
| Dec 31, 2012 | 27.03% |
| Sep 30, 2012 | -321.42% |
| Jun 30, 2012 | 58.74% |
| Mar 31, 2012 | 28.30% |
| Dec 31, 2011 | 25.21% |
| Sep 30, 2011 | 10.90% |
| Jun 30, 2011 | -840.42% |
| Mar 31, 2011 | 90.66% |
| Dec 31, 2010 | -1,401.90% |
| Sep 30, 2010 | 2.68% |